Perceptions of Long-Acting Injectable Antiretroviral Therapy Among People Living with HIV Who Use Drugs and Service Providers: a Qualitative Analysis in Rhode Island-Reference-Cited by-同舟云学术

Perceptions of Long-Acting Injectable Antiretroviral Therapy Among People Living with HIV Who Use Drugs and Service Providers: a Qualitative Analysis in Rhode Island

Published:2023-08-10 Issue:5 Volume:100 Page:1062-1073
ISSN:1099-3460
Container-title:Journal of Urban Health
language:en
Short-container-title:J Urban Health

Author:

Collins Alexandra B.^ORCID,Macon E. Claire,Langdon Kirsten,Joseph Raynald,Thomas Aurielle,Dogon Calli,Beckwith Curt G.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health (social science),Urban Studies

Link

https://link.springer.com/content/pdf/10.1007/s11524-023-00755-6.pdf

Reference33 articles.

1. Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321:451–2.

2. Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society–USA Panel. JAMA. 2018;320(4):379.

3. Charania MR, Marshall KJ, Lyles CM, Crepaz N, Kay LS, Koenig LJ, et al. Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S. based studies, 1996–2011. AIDS Behav. 2014;18:646–60.

4. Dasgupta S, Tie Y, Beer L, Fagan J, Weiser J. Barriers to HIV care by viral suppression status among US adults with HIV: findings from Centers for Disease Control and Prevention medical monitoring project. J Assoc Nurses AIDS Care. 2021;32(5):561–8.

5. Doshi RK, Bowleg L, Blankenship KM. Tying structural racism to human immunodeficiency virus viral suppression. Clin Infect Dis. 2021;72:e646–8.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system;Implementation Science Communications;2024-08-29

2. Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda;BMC Infectious Diseases;2024-08-28

3. Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)’;HIV Medicine;2024-08

4. Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida;AIDS Patient Care and STDs;2024-06-01

5. Incidence of Sexually Transmitted Infections in Youth with HIV During Pre-COVID and COVID Era;AIDS Patient Care and STDs;2024-06-01